Core Scientific, Inc.

CORZ Technology Software Infrastructure

Core Scientific, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319.0 million, down 37.5% from fiscal 2024.

Revenue
+108.8%
EPS
−12.7%
Free cash flow
−852.1%
Total debt
+306.4%

Quarter to June 2026, against a year earlier

11.51 1.25 −9.80%
Market cap
$3.7B
P/E
0.0×
Fwd P/E
−3.2×
Dividend yield
—
F-score
4/9
Altman Z
−1.78
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 0.44
Sold, $m 6.50
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — 1 — — — — 2 1 — —
Sell — — — — 5 4 5 4 5 4 4 1
Insider Ownership 5.19%

Capital & Financial Ratios $m

Size
Market Cap 3,660.00
Revenue ttm 440.31
Net income ttm (1,430.57)
Free cash flow ttm (1,194.74)
Net debt Q 2,362.49
Valuation
P/E 0.00
Forward P/E (3.17) (negative: loss-making)
Price / sales 8.50
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 0.89 (below 1: weak)
Debt / equity Q (1.78) (negative: negative equity)
Interest coverage Q (3.29)
Growth
Revenue growth Q +108.83% (above 0%: growing)
Operating income growth Q −198.54% (below 0%: shrinking)
EPS, this year −389.23% (below 0%: weak)
EPS, next year A +102.35% (at or above 15%: strong)
Revenue, next year A +111.77% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +41.40% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 70 837 311 1,935
Receivables 1 — — —
Inventory — — — —
Other 2 67 584 508
97 904 896 2,444
2023 2024 2025 Q'26
Payables 155 19 126 112
ST’ Debt — — — —
Other — 32 16 1,829
488 135 781 2,738

Compound Annual Growth %

10y 5y 3y
Sales — 39.53% (20.72%)
Cash Flow — 0.00% 10.69%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (1.06) (3.32) — — —
’25 1.25 (2.95) (0.46) 0.42 (0.88)
’24 0.78 (5.05) (1.17) (0.69) (4.87)
’23 0.00 (0.02) (0.11) (0.51) (0.65)
’22 (1.52) (2.49) (1.23) (1.06) (6.30)
’21 0.04 (0.02) (0.07) 0.26 0.20
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 115 164 — — —
’25 80 79 81 80 319
’24 179 141 95 95 511
’23 121 127 113 142 502
’22 193 164 163 121 640
’21 54 75 113 302 544
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 250 (19) — — —
’25 (45) 34 136 153 278
’24 22 1 6 14 43
’23 20 18 5 22 65
’22 (4) 145 (52) 116 205
’21 15 (137) (45) 110 (57)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (137) (815) — — —
’25 (129) (86) (123) (120) (457)
’24 (10) (2) (26) (15) (52)
’23 18 17 3 10 48
’22 (273) (31) (57) (24) (386)
’21 5 (165) (122) 167 (115)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — 60 544 640 502 511 319 440 +39.5% 676 1,148 1,725 +75.5%
Gross margin, % — — — — 15.57 43.87 1.31 24.57 23.71 11.88 28.35 (3.7) pt
EBT — — — — (12) 63 (2,163) (246) (1,437) (288) (1,428) +88.2%
EBT margin, % — — — — (20.24) 11.58 (337.87) (48.93) (281.40) (90.29) (324.28) (70.0) pt
Net income — — — — (12) 47 (2,146) (246) (1,438) (289) (1,431) +88.3%
Per share, $
Per share, $ Revenue — — — — 0.38 2.63 1.88 1.32 2.00 1.00 1.35 +21.3%
Earnings — — — — (0.14) 0.23 (6.30) (0.65) (4.87) (0.88) (4.24) +44.4%
Cash flow — — — — (0.15) (0.27) 0.60 0.17 0.17 0.87 1.60 n/m
Capex — — — — (0.01) (0.28) (1.73) (0.04) (0.37) (2.31) (5.27) +197.7%
Free cash flow — — — — (0.16) (0.56) (1.13) 0.13 (0.20) (1.44) (3.67) +55.0%
Book value — — — — 0.00 6.47 (1.20) (1.57) (3.69) (3.03) (7.44) n/m
Shares, m — — — — 158 207 341 380 256 318 322 +15.1%
Valuation, ×
Valuation, × P/E — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S — — — — 2.60 2.60 2.60 2.60 8.42 14.59 8.50 5.6
P/B — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
EV/Sales — — — — 3.90 3.90 3.90 3.90 8.89 16.93 13.87 6.9
EV/FCF — — — — 40.67 40.67 40.67 40.67 (86.78) (11.81) (5.11) 10.7
Cash, $m
Cash, $m Operating cash flow — — — — (24) (57) 205 65 43 278 520 n/m
Capex — — — — (2) (59) (591) (17) (95) (736) (1,715) +242.2%
Free cash flow — — — — (25) (115) (386) 48 (52) (457) (1,195) +78.4%
Balance, $m
Balance, $m Working capital — — — — — 436 (102) (391) 769 114 (294) (28.5%)
Net debt — — — — — 583 (52) 650 237 749 2,362 +6.5%
Shareholders’ equity — — — — — 1,341 (409) (597) (943) (963) (2,419) n/m
Returns, %
Returns, % ROA — — — — 0.00 3.88 (132.22) (32.44) (113.82) (15.10) (38.84) (15.1) pt
ROIC — — — — 0.00 4.27 0.00 10.53 0.00 0.00 0.00 0.0 pt
ROE — — — — 0.00 0.00 (460.65) 48.99 161.73 30.29 79.25 +30.3 pt
People
People Employees — — — — — — 235 286 325 325 — +11.4%
Revenue/emp, $m — — — — 0.00 0.00 2.72 1.76 1.57 0.98 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

Core Scientific, Inc. vs peers in Software Infrastructure (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DOX Amdocs Limited $4.7B 10.4× 11.4× +2.66% (above 0%: growing) −57.55% (below 0%: shrinking) −18.84% (below 0%: shrinking) 39.76% 8.90% Compare
APPN Appian Corporation $3.9B — (loss-making) 1,228× +25.47% (above 0%: growing) +54.55% (above 0%: growing) −210.79% (below 0%: shrinking) 0.00% 9.08% Compare
DLO DLocal Limited $3.8B 19.2× 15.9× +55.84% (above 0%: growing) +26.67% (above 0%: growing) +12.57% (above 0%: growing) 31.81% 16.05% Compare
PAY Paymentus Holdings, Inc. $3.7B 44.7× 45.6× +19.77% (above 0%: growing) +55.71% (above 0%: growing) +32.10% (above 0%: growing) 25.21% 9.01% Compare
CORZ Core Scientific, Inc. $3.7B — (loss-making) — (loss-making) +108.83% (above 0%: growing) n/m −852.12% (below 0%: shrinking) 42.66% (47.79%)
AVPT AvePoint, Inc. $3.5B 45.6× 57.7× +19.48% (above 0%: growing) +50.00% (above 0%: growing) −13.62% (below 0%: shrinking) 72.20% 8.73% Compare
FOUR Shift4 Payments, Inc. $3.4B 67.6× 28.3× +34.06% (above 0%: growing) −77.14% (below 0%: shrinking) −109.09% (below 0%: shrinking) 34.44% 7.34% Compare
WIX Wix.com Ltd. $3.2B — (loss-making) — (loss-making) +14.93% (above 0%: growing) n/m −64.35% (below 0%: shrinking) 65.77% (10.44%) Compare
BLSH Bullish $3.1B — (loss-making) — (loss-making) −44.34% (below 0%: shrinking) n/m +2.25% (above 0%: growing) 0.25% (0.87%) Compare
Median of peers $3.6B 44.7× 37.0× +19.62% +38.33% −16.23% 33.13% 8.82%

All 183 Software Infrastructure stocks →

Pay and ownership Proxy statement filed 31 March 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 22.92m 74.80m 423.26
2024 41.94m 58.40m 408.43
2022 5.81m (106.96m) —

Ownership

Directors and executive officers, together 1.70%
The Vanguard Group 10.80%
Situational Awareness 9.10%
Pentwater Capital Management LP 8.30%
BlackRock, Inc. 7.40%
Two Seas Capital 5.50%
Susquehanna Securities 5.50%
Citadel Securities 5.40%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Core Scientific, Inc. (CORZ) Latest News

29 Oct

Impact 4 · · Trefis

23 Oct

9 Oct

Impact 4 · · Trefis
Impact 3 · · Trefis

25 Sep

CORZ metrics, ten years each

stockrow.com/CORZ · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com